Teva GTC
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Open Label Extension Study to Protocol C2/13/DR-6MP-02 Crohn's Disease | Phase 2 | 2011-10-01 |
| Terminated | Multicenter Clinical Efficacy and Safety Study of Delayed Release 6MP in Crohn's Disease Crohn's Disease | Phase 1 / Phase 2 | 2010-11-01 |
| Completed | Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Crohns Disease | Phase 1 | 2008-12-01 |
| Terminated | One Year Extension Study To Protocol C2/5/TZ:MS-05 Spasticity, Multiple Sclerosis | Phase 1 / Phase 2 | 2008-01-01 |
| Completed | Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significan Muscle Spasticity | Phase 1 / Phase 2 | 2006-12-01 |
| Completed | Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI) Traumatic Brain Injury | Phase 1 | 2006-12-01 |
| Completed | Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease Crohn's Disease | Phase 1 / Phase 2 | 2006-07-01 |